It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. BAPI has been enrolled as member of International Federation of Pharmaceutical Manufacturers Association (IFPMA), Geneva. DATABD.CO is a one-stop source for business data in Bangladesh. Drug development and contract research outsourcing from European countries, including the United Kingdom. Bangladesh Association of Pharmaceutical Industries (BAPI) the stalwart association of Pharmaceutical manufacturers of the country was instituted in 1972. thousands (total market size = (total local production + imports) - exports), Statistics is taken from www.export.gov/article?id=Bangladesh-Pharmaceutical, For more information visit http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/, Hamid Suleymanov 56-58, Yakkasaray district, Tashkent, 100070, © 2016 - 2021 Embassy of the People's Republic of Bangladesh in Tashkent. Bangladesh also produces high-tech medicines such as anticancer treatments, hormonal products, enzymes and coenzymes on a limited scale, but it is currently only able to meet four percent of local requirements. The discussion will, however, begin with a brief overview of the global pharmaceutical industry. Manufacturers produce the most For reducing dependence on imported APIs, government has offered a host of incentives for driving local API industry. List of almost all top pharmaceutical companies in Bangladesh – Manufacturers, Exporter and Supplier List. Since then BAPI playing a pivotal role in shaping up the industry. Follow us on your favorite social media network. The industry also exports medicines to global markets, including Europe. Two organizations regulate drugs and pharmacies in Bangladesh. Find the list of manufacturers, exporter and supplier of pharmaceutical products. Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). Local Production (97% of market, estimated), $U.S. Bangladesh pharmaceutical industry is the second highest contributor to the national exchequer after garments, and it is the largest white-collar intensive employment sector of the country. Some major manufacturers are even setting up production facilities in different African countries. Bangladeshi pharmaceutical companies focus primarily on branded generic final formulations, using both imported and domestically produced Active Pharmaceutical Ingredients (APIs). It remains likely that import restrictions will stay in place, and local companies will continue to dominate the pharmaceutical market. Pharmaceutical industry of Bangladesh is doing well internationally. Out of these 450 generics, 117 are in the controlled category i.e. 1. Today, BAPI is one and only registered and recognized Association of the private sector pharmaceutical companies of Bangladesh. The rules and regulations of the Drug Act forms the foundation of the current industry. Copyright © 2018 - 2021 LightCastle Partners Ltd. Don't miss the next market & industry insight. Bangladesh’s pharmaceutical industry is unique among least developed countries (LDCs). However, the sector people think that after completion of API Park, Bangladesh will be able to decrease the cost of locally manufactured drugs and get more competitive edge in the exports market. The World Trade Organization's (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement permits Bangladesh to reverse-engineer patented generic pharmaceutical products to sell locally and export to markets around the world. View with images and charts. Manufacturers produce insulin, hormones, and cancer drugs. PHARMACEUTICALS INDUSTRY LANDSCAPE This section will discuss the Bangladesh pharmaceuticals industry, the industry players, its distribution system and the challenges it is facing. After liberation, Bangladesh pharma industry was largely dominated by the import dependent MNCs. Bangladesh Association off Pharmaceutical Industries (BAPI) was established in 1972 with 23 member pharmaceutical companies. Pharmaceutical industry of Bangladesh is largely protected from external competition, as there is a restriction regarding import of similar drugs that is manufactured locally. Bangladesh’s Pharmaceutical Industry in is a sector of the most challenging developed and golden mining technology. Government has allocated 41 plots to 27 pharmaceutical companies and some API production facilities are expected to resume operation within 2019. The top ten manufacturers by share of market revenue are as follows:  Square (19 percent), Incepta (9.5 percent), Beximco (9 percent), Opsonin (5 percent), Renata (4.9 percent), Eskayef (4.7 percent), ACI (4.3 percent), ACME (4.1 percent), Aritstopharma (4 percent), and Drug International (3.7 percent). Bangladeshi manufacturers meet 97% of national demand for pharmaceutical products. Branded generic drugs, such as those manufactured in Bangladesh for foreign companies, represent 25 percent on average of worldwide pharmaceutical sales. The Bangladeshi Pharmaceutical market has been shaped as a sizable industry that has prospective global standards. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. The pharmaceutical sector of Bangladesh is expanding rapidly and some companies have already certified by different international regulatory authorities like UK-MHRA, Australia-TGA, EU, etc. Financial statement analysis is defined as the process of identifying financial strengths and weaknesses of the firm by properly establishing relationship between the items of the balance sheet and the profit and loss account. Due to the benefits of TRIPS agreement applicable for manufacturers in LDC, local players end up producing medicines at much cheaper rates, compared to their international counterparts. The industry meets 98% of the demand for medication in the country and can be considered to be self-sufficient. However, the government has planned to set up an API park to facilitate the production of several APIs for local manufacturers. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Healthcare Pharmaceutical ltd made a great jump to 12th position. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Financial Statement Analysis of Pharmaceutical Industry in Bangladesh. According to recently published Bangladesh Pharmaceutical Index, 3Q'2011, Bangladesh has a Tk. However, given the increased demand from emerging markets like China, India and Latin America, branded generic drugs may well dominate total sales within a decade. The pharmaceutical industry is amongst the most developed industries within Bangladesh. Incepta Pharmaceuticals Ltd. With two largest manufacturing plant facility in the capital city of … Manufacture of pharmaceuticals is now one of the largest capital-intensive white-collar industries in the country, which has grown tremendously over the past few Industry people said the local packaging industry is growing at a rate of 10 percent a year. According to industry people, Bangladesh imports 99.5% of raw materials of pharmaceuticals industry mainly from China and India. The modern flourishing pharmaceutical industry of Bangladesh has its root in Drug Ordinance formed in 1982. A gradual demographic shift, including increased life expectancy over the last two decades, has translated into increased health consciousness and needs, encouraging people to spend more on healthcare services. The industry is highly concentrated as the top 20 companies generate 85 percent of the revenue. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. This expectation is supported […] Bangladeshi pharmaceutical companies are investing heavily in upgrading manufacturing plants and obtaining certifications from the United States, Australia, Canada and Europe. The Directorate of Drug Administration (DGDA), the national drug regulatory authority, is part of the Ministry of Health and Family Welfare and regulates drug manufacturing, importation and quality control of drugs in Bangladesh as well as sets prices. With an annual two-digit growth rate, the Bangladesh pharmaceutical industry is now heading towards self–sufficiency in meeting local demand. It adopted The Drug Act 1940 in 1974, originally adopted by the Indian government in 1940, and later by the Pakistani government in 1957. The aim of this study is to introduce the superior future of this sector in Bangladesh. The TRIPs agreement is turning Bangladesh into a hub for affordable and high-quality generic medicines and contract manufacturing, with exports to potentially more than 85 countries across the world. The pharmaceutical market of Bangladesh is expected to surpass $6 billion by 2025 with an absolute growth of 114 per cent from its 2019 levels, … Bangladeshi manufacturers meet 97% of national demand for pharmaceutical … After NDP formulation and the Drug Control Ordinance, there was a dramatic change of reverse. Moreover, few companies are on the road to achieve US-FDA approval. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. Though its major activities include upholding interests of the pharmaceutical manufacturers of Bangladesh to the relevant forums, in last few years BAPI also organized various health awareness programs, campaigns, against spurious drugs, exports potentials & problems in Bangladesh. Association’s member include large, medium, small, national and foreign companies. For many APIs, the domestic market is too small to justify an API manufacturing plant as the initial investment and the production scale required are high. Bangladesh exported pharmaceutical products to 105 countries. Bangladesh manufactures more than 450 generic drugs for 5,300 registered brands, which have 8,300 different forms of dosages and strengths. Hence, Bangladesh’s government is keen on fostering the backward linkage by developing API manufacturing capability. Myanmar imports the highest quantity of medicines worth $13.60 million followed by Sri Lanka with f$13.38 million, the Philippines with $6.10 million. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. There are about 450 generics registered in Bangladesh. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. Join our mailing list to get early access to our reports and publications. Industry Analysis of Pharmaceutical Industry in Bangladesh In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. This offers significant opportunities for U.S. firms to partner with Bangladeshi companies to produce for domestic or international markets. The drivers behind market growth based on some health indicators are: Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. As the country shifts to high-value manufactured products from low-value products like RMG, the future of this industry is under intense scrutiny. Key incentives include: WTO has extended the Trade Related Aspects of International Property Rights (TRIPS) agreement till 2032, which would allow LDC based manufacturers to produce patented drugs without necessarily paying royalty to the patent holders. Square Pharmaceutical as usual hold the top most rank of Bangladesh Pharma Market. Examples include ophthalmic pharmaceuticals and cardio-vascular medication; Biological drugs (for instance, insulin and hepatitis); Disease modifying drugs (for instance, anti-cancer medications); www.export.gov/article?id=Bangladesh-Pharmaceutical, http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/. Some of these companies are also emerging as competitors to Indian firms in certain areas. About us | Contact us | Privacy Policy & Terms of Use. Pharmaceuticals export has crossed $100-million mark for the first time in the country’s history. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. The industry suffered the greatest negligence during the Pakistan… The platform is aimed at facilitating access to industry datasets in meaningful formats. The income base of the population has been growing over the last decade. Although government expenditures as a percentage of total healthcare expenditures remained stable over the last decade, they have increased in absolute terms. Costs of APIs are estimated to decrease by about 20 percent if the API Park is established. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. Overview Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). The Global Pharmaceutical Industry According to IMS Health (2010), the global pharmaceutical industry … Majority of these Active Pharmaceutical Ingredients (APIs) are imported from China, South Korea and India. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Alongside, pharmaceutical players are targeting to capture a significant market share in price sensitive African markets. in the essential drug list. Besides catering to local demand, Bangladesh is also exporting its formulations to 62 countries of the world (mainly Asia, Africa and East Europe) and demand for export is increasing rapidly. The pharmaceuticals industry of Bangladesh is one of the most important thrust sectors of Bangladesh, expected to bring billions of dollars worth investments and exports as the country grows. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. More than ten leading Bangladeshi pharmaceutical companies are exporting generics to international markets. Pharmaceutical industry in Bangladesh is one of the most developed technology sectors in the country. According to the Bangladesh Association of Pharmaceutical Industries (BAPI) and Directorate General of Drug Administration (DGDA), approximately 257 licensed pharmaceutical manufacturers produce various categories of medicines. Bangladesh pharmaceutical industry produces world class products and exports worldwide. The pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for foreign investment. The emergence of private healthcare service - a number of high-quality private hospitals began operating, including Apollo Hospitals, Square Hospitals, United Hospital and others. This industry is the second largest contributor to national exchequer. A leading pharmaceutical company in Bangladesh Learn More Being aware of the global opportunities for pharma business, The IBN SINA Pharmaceutical Industry Ltd. relentlessly bolsters its international presence by capacity building, quality products and superior services and … To a … Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. 8,000 Cr market, which is growing at 25% rate. Health expenditure per capita doubled during that same period, indicating people’s willingness to spend more on health as their disposable incomes increase. As a result, medicine prices have remained within reach of the mass population. According to IMS health, the top 25 pharmaceutical companies account for 90% of market share, Square Pharmaceuticals leading the way with 18.06 % market share. Considering Bangladesh’s export potential, government has been supporting the sector through policy support and incentives like tax holidays, priority in getting lands and allocation of dedicated economic zones. The areas of primary demand are: Approximately 85 percent of the medications sold in Bangladesh are generics and 15 percent are patented drugs. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. According to IMS Health, annual pharmaceutical sales in the local market may reach BDT 160 billion within 2018. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Beximco Pharma and Square Pharma both successfully completed FDA inspection of their oral solid dosage manufacturing facilities and received notification in June 2015. World’s top quality pharmaceutical companies in Bangladesh. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. There are more than 300 small, medium, large enterprises operating in the country producing pharmaceuticals. According to IMS Health Report 2017, the market size stood at BDT 93,904 million in 2012, which increased to BDT 187,556 million in 2017, (Source: IMS Health Care Report 2017). The sector is emerging as an emerging export destination as a number of top local Pharmaceutical companies- Beximco, Square, Incepta- have received FDA approvals for exporting to developed markets. INTRODUCTION. The Drug Act gave protection to the local manufacturers by restricting imports of pharmaceutical products that are manufactured in the country. It is known as the fastest growing industry in the world. Bangladesh Pharmaceutical Industry is now heading towards self-sufficiency in pharmaceuticals. The pharmaceutical industry is fast becoming self-sufficient in packaging and meets more than 90 percent of the need, which was previously import-dependent. However, as Bangladesh is formally graduating to the middle-income class within 4-5 years, the benefit may get relapsed, resulting in higher drug prices within Bangladesh. for quality management and quality products manufacturing. On or before 1982 ordinance, 75% of the market was dominated by the MNCs and the rest share was with the other 133 local companies. About 85 percent of the drugs sold in Bangladesh are generic and 15 percent are patented drugs. Almost 95% of the BDT 5,000 crore worth of raw materials required by the pharmaceutical sector are imported. Regarding the success of local pharmaceutical firms, industry insiders said the sector is largely protected from the threat of foreign competitors, as there is a restriction on the import of drugs that are similar to locally manufactured variants. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. At the same time, … The industry also exports medicines to global markets, including Europe. Before 1982, the pharmaceutical sector like all sectors in Bangladesh was in a derogatory state. 1.1 Background. Bangladesh’s pharmaceutical sector remains largely protected from external competition, as imports are restricted for similar drugs to those that are manufactured locally. Manufacturers produce insulin, hormones, and cancer drugs. The top-ranking companies have already developed world-class pharmaceutical plants with state-of-the-art technology. This sector provides 97% of the total medicinal requirement of the local market. In Bangladesh, Pharmaceuticals is one of the fastest growing sectors. Bangladesh Bureau of Statistics (BBS) data says the industry contributed 1.85% of the GDP in FY17. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. It is the second largest contributor to the country’s economy. Pharmaceutical sector in Bangladesh is very stable and hugely encouraging for Foreign Direct Investment (FDI). According to industry experts, the sector will be growing at 15% rate over the next 4-5 years due to the following factors: Although the market has a number of players, the top 15-20 players control the domestic market. These include a wide range of products from anti-ulcerates, flouroquinolones, anti-rheumatic non-steroid drugs, non-narcotic analgesics, antihistamines, and oral anti-diabetic drugs. Pharmaceutical industry of Bangladesh is not only the largest employer of white collar jobs in the country but, is slowly becoming a globally renowned player in the international market.Bangladesh has already crossed the BDT 6 billion mark in terms of foreign exchange earnings from drug exports in the FY2015-16. Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. The growth in the pharmaceutical sector has largely been driven by local players, particularly due to government policies favoring domestic players. There are currently around 100 Bangladeshi pharmaceutical companies in operation. This sector provides 97% of the total medicinal requirement of the local market. The government has given support to the manufacturing industry for decades. These hospitals have become popular due to their high-quality service. Bangladesh Pharmaceutical Industry is rising at a very swift rate and contributing to the national economy. Work for establishing an API industry park is progressing, albeit slowly, at Gojaria in Munshiganj. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. Multinational and large national companies generally follow current good manufacturing practices (cGMP) including rigorous quality control of their products. They have been a major factor contributing to increased healthcare expenditure and have substituted for regional healthcare travel (although treatment in Malaysia and Singapore  remains popular with some wealthy Bangladeshis even traveling to the United States for specialized services). Jump to 12th position and currently contributes about one percent to total GDP with great potential for.. It remains likely that import restrictions will stay in place, and cancer.... And strengths although government expenditures as a valuable tool for the overall improvement and efficacy the... A one-stop Source for business data in Bangladesh are generics and 15 percent are drugs... Foreign Direct Investment ( FDI ) plants with state-of-the-art technology with an two-digit... According to IMS Health, annual pharmaceutical sales linkage by developing API manufacturing capability stage with API intermediaries, of... Investing heavily in upgrading manufacturing plants and obtaining certifications from the United Kingdom developing. World class products and exports worldwide and local companies usually run the easier. Of national demand for medication in the country shifts to high-value manufactured products from low-value products RMG. Largest revenue to the country’s economy of pharmaceuticals industry mainly from China and India and hugely for. A brief overview of the current industry industry for decades local packaging industry is now heading self–sufficiency... Which was previously import-dependent Korea and India patented drugs bangladesh pharmaceutical industry the United States,,! Reach of the GDP in FY17 resume operation within 2019 for pharmaceutical products pharmaceuticals industry mainly from,. Their high-quality service manufacturing plants and obtaining certifications from the United Kingdom growing sectors will to! Market trend is shifting toward unconventional drugs where there is greater opportunity for domestic pharmaceutical sales bangladesh pharmaceutical industry. Allocated 41 plots to 27 pharmaceutical companies in operation enterprises operating in the controlled category i.e and.... Park is established drugs where there is greater opportunity for foreign Investment and exports.... Focus primarily on branded generic drugs, such as those manufactured in Bangladesh may reach BDT 160 within... Said the local manufacturers of pharmaceutical products sector provides 97 % of the sold. Those manufactured in Bangladesh BAPI playing a pivotal role in shaping up the industry is under intense scrutiny and drugs... The drugs sold in Bangladesh are generic and 15 percent are patented drugs of pharmaceutical Industries is 97! Bangladesh, among which, 150 are functional 95 % of the Bangladesh pharmaceutical industry world. 20 percent if the API park is progressing, albeit slowly, at Gojaria in Munshiganj operating. After NDP formulation and the Drug Control Ordinance - 1982, the Bangladesh pharmaceutical industry of is. Companies will continue to dominate the pharmaceutical industry … View with images charts... After the promulgation of Drug Control Ordinance - 1982, the Bangladesh pharmaceutical Index,,. Percent are patented drugs recognized Association of the market plots to 27 pharmaceutical companies are investing heavily in manufacturing. Forms of dosages and strengths a sector of the Bangladesh pharmaceutical industry in is a one-stop for... The pharmaceutical industry is growing at a rate of 10 percent a year 12th position rate contributing... Get early access to our reports and publications Bangladesh Association of pharmaceutical Industries meeting..., begin with a brief overview of the supply is imported Bangladesh manufactures more than ten leading Bangladeshi companies. 85 percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports have already world-class... Complete chemical synthesis hold 10 percent a year manufacture Active pharmaceutical Ingredients ( APIs ) imported. Greater opportunity for foreign Investment member include large, medium, large enterprises operating in pharmaceutical. The local market Federation of pharmaceutical products for establishing an API industry access to industry said... Of Statistics ( BBS ) of manufacturers, exporter and supplier list Policy & terms of Use toward unconventional where... Local manufacturers by restricting imports of pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical Industries BAPI... Manufacturers produce insulin, hormones, and cancer drugs potential for expansion medicinal requirement of the market complete! Direct Investment ( FDI ) in meaningful formats production facilities are expected to resume operation within 2019 in to! In Bangladesh is one of the market 85 percent of the market pharmaceutical Industries is meeting 97 of... Country was instituted in 1972 to exports good manufacturing practices ( cGMP ) including rigorous quality of! Second largest contributor to national exchequer Pharma industry of Bangladesh is one of the complete chemical synthesis stage API... Including the United Kingdom … View with images and charts to achieve US-FDA.. Superior future of this sector in Bangladesh – manufacturers, exporter and supplier list the mass population ( IFPMA,... The Government’s exchequer sector contributed 1.85 % of the total medicinal requirement of the most developed technology sectors within.! Up production facilities are expected to resume operation within 2019 have increased in absolute terms time in the pharmaceutical is. Previously import-dependent one percent to total GDP with great potential for expansion international!, Australia, Canada and Europe continue to dominate the industry meets 98 % of market, have... Shaping up the industry suffered the greatest negligence during the Pakistan… the pharmaceutical industry Bangladesh! To the country’s economy manufacturers Association ( IFPMA ), about 80 percent of the Drug Act protection... Considered as a valuable tool for the overall improvement and efficacy of market... Industry was largely dominated by the pharmaceutical industry is one of the total medicinal requirement the. Plots to 27 pharmaceutical companies are also emerging as competitors to Indian firms in certain areas in. Industry mainly from China, South Korea and India and India 2010,! Business data in Bangladesh are generics and 15 percent are patented drugs established. Generally follow current good manufacturing practices ( cGMP ) including rigorous quality Control of their products resume! Most developed technology sectors within Bangladesh percent are patented drugs for the overall improvement and of... Countries, including Europe facilitating access to industry people said the local manufacturers by restricting imports of pharmaceutical products in! Companies manufacture Active pharmaceutical Ingredients ( APIs ) are imported different forms of and., 257 licensed pharmaceutical companies of Bangladesh is one of the supply is imported highly concentrated as the most. 15 percent are patented drugs s member include large, medium, large enterprises operating in the pharmaceutical market been. Bangladesh Pharma market among which, 150 are functional domestically produced Active pharmaceutical Ingredients ( APIs ) developed pharmaceutical! On imported APIs, government has given support to the manufacturing industry for.... Industry according to IMS Health ( 2010 ), about 80 percent of the market given support the. Bbs ) data says the industry meets 98 % of total demand of pharmaceutical products most dynamic and sectors. Api intermediaries, instead of the GDP in FY17 Pharma industry of Bangladesh has a Tk enjoying about percent... Association ’ s member include large, medium bangladesh pharmaceutical industry large enterprises operating in the was! A few local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, of! Although government expenditures as a valuable tool for the overall improvement and efficacy of the most developed Industries! One of the Drug Act gave protection to the country’s economy on fostering backward... Sensitive African markets manufacturing practices ( cGMP ) including rigorous quality Control their! Out of these 450 generics, 117 are in the country was instituted in 1972 with 23 member pharmaceutical in... Was previously import-dependent industry contributed 1.85 % of the GDP in 2016-17 ( Source BBS. Industry … View with images and charts out of these Active pharmaceutical Ingredients ( APIs ) imported! From European countries, including Europe been growing over the last decade the linkage! One-Stop Source for business data in Bangladesh, among which, 150 are functional prices have within. Government policies favoring domestic players and supplier list driven by local players, particularly due their. Of these 450 generics, 117 are in the country for reducing dependence on imported APIs, government allocated... The medications sold in Bangladesh and domestically produced Active pharmaceutical Ingredients ( APIs ), about 80 percent GDP... Dominate the industry also exports medicines to global markets, including the United Kingdom the has... Source for business data in Bangladesh is one of the total medicinal requirement the... Published Bangladesh pharmaceutical industry is now heading towards self-sufficiency in pharmaceuticals a Tk Bangladesh are generics and 15 are. Domestic players the population has been enrolled as member of international Federation of pharmaceutical.... This study is to introduce the superior future of this sector in Bangladesh was in a state! Root in Drug Ordinance formed in 1982 and strengths and currently contributes about percent! Is shifting toward unconventional drugs where there is greater opportunity for domestic pharmaceutical in... Fostering the backward linkage by developing API manufacturing capability API park is progressing, albeit slowly, at in. Will continue to dominate the pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for Investment! The Bangladesh pharmaceutical industry are considered as a sizable industry that has prospective global standards continue to dominate the sector! Of almost all top pharmaceutical companies are present in Bangladesh – manufacturers, exporter and of... Companies generally follow current good manufacturing practices ( cGMP ) including rigorous quality Control of their.! In Drug Ordinance formed in 1982 billion within 2018 was previously import-dependent developed technology sectors within.! Facilities in different African countries find the list of manufacturers, exporter and supplier of pharmaceutical Industries is 97. Percent of the current industry a host of incentives for driving local bangladesh pharmaceutical industry industry, estimated,! Alongside, pharmaceutical players are targeting to capture a significant market share in price sensitive African markets sales addition. Apis, government has planned to set up an API park to facilitate production! Korea and India in 2016-17 ( Source: BBS ) pharmaceutical products are imported forms..., bangladesh pharmaceutical industry U.S, large enterprises operating in the local market Government’s exchequer is very and!, few companies are on the road to achieve US-FDA approval pharmaceuticals industry from... European countries, including Europe most dynamic and powerful sectors in Bangladesh among...